Inventiva is a clinical stage biotechnology research company delivering therapies in the areas of oncology, fibrosis and rare diseases. The most advanced clinical programs (IVA337 for systemic sclerosis in Non-Alcoholic Steato-Hepatitis and IVA336 for Maroteaux-Lamy syndrome-MPS VI) have demonstrated efficacy in relevant in vivo and in vitro models as well as safety in phase I and phase II clinical trials. Using its in-house drug discovery platform, which covers target validation, screening, chemistry, ADME and pharmacology, Co. is developing an internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets and nuclear receptors.

NSE SA. NSE Industries SA, (formerly known as ECT Industries SA), is a France-based company engaged in the manufacture of electronic systems for the aviation, naval and transport industries. The Company's activities are organized around six divisions: Night Vision Systems, including night vision goggles, NVG compatible lights and cockpit modifications; Usage Monitoring Systems (UMS), such as the Brite Saver; satellite communication systems and software; On Board Equipment, including platforms for airborne applications, power converters, airborne phones and avionic control panels; Maintenance Services and management of obsolescence and negotiation services; Satellites Communication Systems and Railway Signals and Systems. The Company has eight facilities in France: Emerainville, Maillane, Taverny, Brive, Bayo, Toulon, Soyons and e-Track systems. ECT Industries SA's wholly owned subsidiaries include Bayo SAS and e-Track systems.

Quantum Gernomics is a biotechnology firm specializing in the development of innovative drugs to combat cardiovascular diseases. Run by professionals in creating and managing technological start-ups and drug development, as well as researchers and inventors, Co. has established contractual relations with institutions of academic excellence in France (Inserm, CollA

Theradiag SA is a France-based company which develops and markets biological diagnostic tools. The Company develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. TheraDiags product offering consists of tests using a range of techniques (Elisa, rapid tests, immunofluorescence, Dot, immunochemical tests, molecular biology, etc.) as well as a range of automatic devices and solutions for high-speed diagnostics based on Luminexs Multiplex technology. It has also developed a range of theranostic diagnostics commercialized under the Lisa-Tracker brand which provide monitoring of patients treated by anti-TNF monoclonal antibodies. TheraDiag is active in more than 30 countries, as an independent distributor.